Adeno-associated virus-mediated osteoprotegerin gene transfer protects against joint destruction in a collagen-induced arthritis rat model

Joint Bone Spine

Volumn 79, Issue 5, 2012, Pages 482-487

  Bao, Lizhi ^a   Zhu, Tingting ^a   Zhao, Dongbao ^a   Han, Xinhai ^a   Guan, Jianlong ^a   Shi, Zhiqing ^a   Zhang, Lanlin ^a  

^a SECOND MILITARY MEDICAL UNIVERSITY   (China)

Author keywords

Collagen induced arthritis; Gene therapy; Osteoclast; Osteoprotegerin; RAAV hOPG

Indexed keywords

ADENOVIRUS VECTOR; ENHANCED GREEN FLUORESCENT PROTEIN; INTERLEUKIN 1BETA; OSTEOPROTEGERIN; STROMELYSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTHRITIS; ARTICLE; CONTROLLED STUDY; FROZEN SECTION; IN VIVO STUDY; JOINT DESTRUCTION; MALE; NONHUMAN; PROTEIN EXPRESSION; RAT; SYNOVIUM; VIRAL GENE THERAPY;

ANIMALS; ARTHRITIS, EXPERIMENTAL; ARTHROGRAPHY; DEPENDOVIRUS; DISEASE MODELS, ANIMAL; GENE TRANSFER TECHNIQUES; GENETIC THERAPY; INTERLEUKIN-1BETA; JOINTS; MALE; MATRIX METALLOPROTEINASE 3; OSTEOPROTEGERIN; RATS; RATS, SPRAGUE-DAWLEY;

EID: 84867988107     PISSN: 1297319X     EISSN: 17787254     Source Type: Journal    
DOI: 10.1016/j.jbspin.2011.10.011     Document Type: Article

References (27)

1. Kojiro S., Hiroshi T. Osteoclasts, rheumatoid arthritis, and osteoimmunology. Curr Opin Rheumatol 2006, 18:419-426.
2. Johnell O., Hulth A. Proliferation of osteoclasts in rat bone following bleeding and femoral fractures. Calcif Tissue Int 1977, 23:241-244.
3. Tsuboi H., Matsui Y., Hayashida K., et al. Tartrate resistant acid phosphatase (TRAP) positive cells in rheumatoid synovium may induce the destruction of articular cartilage. Ann Rheum Dis 2003, 62:196-203.
4. Gradaigh D.O., Ireland D., Bord S., et al. Joint erosion in rheumatoid arthritis: interactions between tumour necrosis factor α, interleukin 1, and receptor activator of nuclear factor κB ligand (RANKL) regulate osteoclasts. Ann Rheum Dis 2004, 63:354-359.
5. Shilpi A., Ramnath M., Amita A. Synovial fluid RANKL and matrix metalloproteinase levels in enthesitis related arthritis subtype of juvenile idiopathic arthritis. Rheumatol Int 2008, 29:907-911.
6. de Amorim F.P., Ornelas S.S., Diniz S.F., et al. Imbalance of RANK, RANKL and OPG expression during tibial fracture repair in diabetic rats. J Mol Hist 2008, 39:401-408.
7. Crotti T.N., Ahern M.J., Lange K., et al. Variability of RANKL and osteoprotegerin staining in synovial tissue from patients with active rheumatoid arthritis: quantification using color video image analysis. J Rheumatol 2003, 30:2319-2324.
8. Geusens P.P., Landewe R.B., Garnero P., et al. The ratio of circulating osteoprotegerin to RANKL in early rheumatoid arthritis predicts later joint destruction. Arthritis Rheum 2006, 54:1772-1777.
9. Sundeep K. Minireview: the OPG/RANKL/RANK System. Endocrinology 2001, 142:5050-5055.
10. Bolon B., Shalhoub V., Kostenuik P.J., et al. Osteoprotegerin, an endogenous antiosteoclast factor for protecting bone in rheumatoid arthritis. Arthritis Rheum 2002, 46:3121-3135.
11. Jin Q., Cirelli J.A., Park C.H., et al. RANKL inhibition through osteoprotegerin blocks bone loss in experimental periodontitis. J Periodontol 2007, 78:1300-1308.
12. Adriaansen J., Tas S.W., Klarenbeek P.L., et al. Enhanced gene transfer to arthritic joints using adeno-associated virus type 5: implications for intra-articular gene therapy. Ann Rheum Dis 2005, 64:1677-1684.
13. Watanabe S., Imagawa T., Boivin G.P., et al. Adeno-associated virus mediates long-term gene transfer and delivery of chondroprotective IL-4 to murine synovium. Mol Ther 2000, 2:147-152.
14. Cottard V., Mulleman D., Bouille P., et al. Adeno-associated virus-mediated delivery of IL-4 prevents collagen-induced arthritis. Gene Ther 2000, 7:1930-1939.
15. Apparailly F., Millet V., Noel D., et al. Tetracycline-inducible interleukin-10 gene transfer mediated by an adeno-associated virus: application to experimental arthritis. Hum Gene Ther 2002, 13:1179-1188.
16. Pan R.Y., Chen S.L., Xiao X., et al. Therapy and prevention of arthritis by recombinant adeno-associated virus vector with delivery of interleukin-1 receptor antagonist. Arthritis Rheum 2000, 43:289-297.
17. Zhang H.G., Xie J., Yang P., et al. Adeno-associated virus production of soluble tumor necrosis factor receptor neutralizes tumor necrosis factor alpha and reduces arthritis. Hum Gene Ther 2000, 11:2431-2442.
18. Chan J.M., Villarreal G., Jin W.W., et al. Intraarticular gene transfer of TNFR:Fc suppresses experimental arthritis with reduced systemic distribution of the gene product. Mol Ther 2002, 6:727-736.
19. Takahashi H., Kato K., Miyake K., et al. Adeno-associated virus vector-mediated anti-angiogenic gene therapy for collagen-induced arthritis in mice. Clin Exp Rheumatol 2005, 23:455-461.
20. Ulrich-Vinther M. Gene therapy methods in bone and joint disorders. Evaluation of the adeno-associated virus vector in experimental models of articular cartilage disorders, periprosthetic osteolysis and bone healing. Acta Orthop Suppl 2007, 78:1-64.
21. Mori H., Kitazawa R., Mizuki S., et al. RANK ligand, RANK, and OPG expression in type II collagen-induced arthritis mouse. Histochem Cell Biol 2002, 117:283-292.
22. Yin G., Liu W., An P., et al. Endostatin gene transfer inhibits joint angiogenesis and pannus formation in inflammatory arthritis. Mol Ther 2002, 5:547-554.
23. Rau R., Herborn G. A modified version of Larsen's scoring method to assess radiologic changes in rheumatoid arthritis. J Rheumatol 1995, 22:1976-1982.
24. Romas E., Sims N.A., Hards D.K., et al. Osteoprotegerin reduces osteoclast numbers and prevents bone erosion in collagen-induced arthritis. Am J Pathol 2002, 161:1419-1427.
25. Judex M.O., Mueller B.M. Plasminogen activation/plasmin in rheumatoid arthritis: matrix degradation and more. Am J Pathol 2005, 166:645-647.
26. Stolina M., Schett G., Dwyer D., et al. RANKL inhibition by osteoprotegerin prevents bone loss without affecting local or systemic inflammation parameters in two rat arthritis models: comparison with anti-TNFalpha or anti-IL-1 therapies. Arthritis Res Ther 2009, 11:R187.
27. Saidenberg-Kermanac'h N., Corrado A., Lemeiter D., et al. TNF-α antibodies and osteoprotegerin decrease systemic bone loss associated with inflammation through distinct mechanisms in collagen-induced arthritis. Bone 2004, 35:1200-1207.